Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Impact of ureteral stenting prior to ureterorenoscopy on stone-free rates and complications.

Lumma PP, Schneider P, Strauss A, Plothe KD, Thelen P, Ringert RH, Loertzer H.

World J Urol. 2013 Aug;31(4):855-9. doi: 10.1007/s00345-011-0789-6. Epub 2011 Oct 29. Review.

2.

A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo.

DeFeo-Jones D, Brady SF, Feng DM, Wong BK, Bolyar T, Haskell K, Kiefer DM, Leander K, McAvoy E, Lumma P, Pawluczyk JM, Wai J, Motzel SL, Keenan K, Van Zwieten M, Lin JH, Garsky VM, Freidinger R, Oliff A, Jones RE.

Mol Cancer Ther. 2002 May;1(7):451-9.

3.

Design and synthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity.

Brady SF, Pawluczyk JM, Lumma PK, Feng DM, Wai JM, Jones R, DeFeo-Jones D, Wong BK, Miller-Stein C, Lin JH, Oliff A, Freidinger RM, Garsky VM.

J Med Chem. 2002 Oct 10;45(21):4706-15.

PMID:
12361397
4.

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.

Garsky VM, Lumma PK, Feng DM, Wai J, Ramjit HG, Sardana MK, Oliff A, Jones RE, DeFeo-Jones D, Freidinger RM.

J Med Chem. 2001 Nov 22;44(24):4216-24.

PMID:
11708923
5.

A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo.

DeFeo-Jones D, Garsky VM, Wong BK, Feng DM, Bolyar T, Haskell K, Kiefer DM, Leander K, McAvoy E, Lumma P, Wai J, Senderak ET, Motzel SL, Keenan K, Van Zwieten M, Lin JH, Freidinger R, Huff J, Oliff A, Jones RE.

Nat Med. 2000 Nov;6(11):1248-52.

PMID:
11062536
6.

Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites.

Dunwiddie CT, Neeper MP, Nutt EM, Waxman L, Smith DE, Hofmann KJ, Lumma PK, Garsky VM, Vlasuk GP.

Biochemistry. 1992 Dec 8;31(48):12126-31. Erratum in: Biochemistry 1993 Mar 30;32(12):3196.

PMID:
1457408
7.

Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor protein.

Jones RE, Heimbrook DC, Huber HE, Wegrzyn RJ, Rotberg NS, Stauffer KJ, Lumma PK, Garsky VM, Oliff A.

J Biol Chem. 1992 Jan 15;267(2):908-12.

8.

Proton NMR assignments and secondary structure of the snake venom protein echistatin.

Chen Y, Pitzenberger SM, Garsky VM, Lumma PK, Sanyal G, Baum J.

Biochemistry. 1991 Dec 17;30(50):11625-36.

PMID:
1661142
9.
10.

Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs.

Garsky VM, Lumma PK, Freidinger RM, Pitzenberger SM, Randall WC, Veber DF, Gould RJ, Friedman PA.

Proc Natl Acad Sci U S A. 1989 Jun;86(11):4022-6.

11.

Prominent depressor response to endothelin in spontaneously hypertensive rats.

Winquist RJ, Bunting PB, Garsky VM, Lumma PK, Schofield TL.

Eur J Pharmacol. 1989 Apr 12;163(1):199-203.

PMID:
2663529
12.

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.

Darke PL, Nutt RF, Brady SF, Garsky VM, Ciccarone TM, Leu CT, Lumma PK, Freidinger RM, Veber DF, Sigal IS.

Biochem Biophys Res Commun. 1988 Oct 14;156(1):297-303.

PMID:
3052448
13.
14.

Synthesis of (7R)-7H-indolo[3,4-gh][1,4]benzoxazines, a new class of D-heteroergolines with dopamine agonist activity.

Anderson PS, Baldwin JJ, McClure DE, Lundell GF, Jones JH, Randall WC, Martin GE, Williams M, Hirshfield JM, Clineschmidt BV, Lumma PK, Remy DC.

J Med Chem. 1983 Mar;26(3):363-7.

PMID:
6298427
15.

2-pyridylimidazoles as inhibitors of xanthine oxidase.

Baldwin JJ, Lumma PK, Novello FC, Ponticello GS, Sprague JM, Duggan DE.

J Med Chem. 1977 Sep;20(9):1189-93.

PMID:
926119
16.

An approach to peripheral vasodilator-beta-adrenergic blocking agents.

Baldwin JJ, Hirschmann R, Lumma PK, Lumma WC Jr, Ponticello GS, Sweet CS, Scriabine A.

J Med Chem. 1977 Aug;20(8):1024-9.

PMID:
19628

Supplemental Content

Support Center